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Upper respiratory tract infections
Daycare centers
S U M M A R Y
Objective: To compare the clinical outcomes (duration of signs and symptoms) and the microbiology in
Mexican children with non-complicated febrile upper respiratory tract infections (URI), with and
without the use of antibiotics.
Methods: We conducted a prospective cohort study from September 2006 to July 2007. The study
population consisted of 880 children aged 6 months to 5 years 11 months, attending four community
daycare centers run by the Instituto Mexicano del Seguro Social (IMSS) and three non-IMSS daycare
centers. Children with a febrile URI were enrolled before receiving any antimicrobials and were followed
up for two weeks. Duration of the fever, cough, runny nose, stuffy nose, irritability, loss of appetite,
tiredness, and diarrhea, and isolation of Haemophilus inﬂuenzae, Streptococcus pneumoniae, and
Streptococcus pyogenes were compared in those children who received antibiotic treatment and those
who did not receive antibiotics.
Results: During the study period, a total of 145 out of 880 children were enrolled, and among those
enrolled, 85/145 (59%) children received antibiotics. There was no signiﬁcant difference in the duration
of the signs and symptoms evaluated in the two groups. Although the proportions of S. pneumoniae, H.
inﬂuenzae, and S. pyogenes isolated in children with and without antibiotics were comparable, those in
whom we isolated S. pneumoniae had both a signiﬁcantly longer episode of URI, as well as longer lasting
diarrhea. Similarly, children receiving trimethoprim–sulfamethoxazole treatment experienced signiﬁ-
cantly longer durations of fever and diarrhea.
Conclusions: Themean duration of signs and symptoms and themicrobiological isolates of children with
febrile URI were comparable among children treated with or without antibiotics, with the exception of a
longer duration of URI and diarrhea in those children with an S. pneumoniae isolate. Our ﬁndings suggest
that in our population, most cases of febrile URI are caused by viral infections, and demonstrate that
antibiotics should not be used routinely in children with non-complicated febrile URI.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Acute upper respiratory tract infections (URI) are themain cause
for seeking primarymedical attention inMexico. During 2007, over
23 million cases were reported in the Epidemiological Weekly
Report.1 Children under 5 years of age and cared for at homeby their
mother, suffer up to six URI a year,2,3 with a greater incidence in
those under 2 years of age.4 The annual number of URI in children
attending daycare centers can be almost double this ﬁgure.5 The* Corresponding author. William Cameron, Ottawa, Canada.
Tel.: +52 33 3668 3000x31953; fax: +52 33 3618 1756.
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doi:10.1016/j.ijid.2010.02.2250majority of cases (80–90%) are caused by viral agents (adenovirus,
respiratory syncytial virus, parainﬂuenza A and B viruses),with only
occasional cases caused by bacteria (Streptococcus pneumoniae,
Haemophilus inﬂuenzae, and Streptococcus pyogenes). Therefore, we
believe that the management of URI should be conservative.
The symptoms of URI are characterized by a sudden onset, with
clear nasal secretions that can become purulent, stuffy nose, cough,
tiredness, sneezing, and on occasions fever, which decreases after
72 h. All signs and symptoms are usually self-limiting, lasting 7–10
days.6
Although the majority of non-febrile URI receive home-based
treatment with symptomatic medications, vitamins, and folk
remedies, in Mexico, as in other underdeveloped countries, up to
80–85% of patients with a febrile URI receive antibiotics.7–9 Oneses. Published by Elsevier Ltd. All rights reserved.
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febrile URI is that their use gives a feeling of ‘security or protection’,
both to the physician and to the parents.10 However, this behavior
is a risk factor for the selection and development of antibiotic-
resistant bacteria.11–14
Wewere therefore interested in assessing twomajor issues: (1)
the duration of signs and symptoms of febrile URI in children
attending daycare centers who receive antibiotics compared to
those who do not, and (2) the frequency of nasopharyngeal
isolation of S. pneumoniae, H. inﬂuenzae, and S. pyogenes in those
who receive antibiotics and those who do not.
2. Methods
2.1. Study population
We conducted a prospective study from September 2006 to July
2007. We evaluated 880 children aged between 6 months and 5
years 11 months attending four Instituto Mexicano del Seguro
Social (IMSS) daycare centers and three non-IMSS private daycare
centers in the metropolitan area of Guadalajara, Mexico.
Only those children presenting with a febrile (38 8C) URI
episode documented by the nurse during his/her stay at the
daycare center were included in the study. A nasopharyngeal
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Figure 1. Flow diagramdepicting diagnostic and therapeutic features among 153 children
cohort of 880 children evaluated at daycare centers in the metropolitan area of Guadaculture was performed in these children, and they were followed
up by phone calls and/or through interviews with the parents at
the daycare center. Contactwasmade on the ﬁrst day of illness, and
then every other day over a period of two weeks. Parents were
questioned about the duration of associated signs and symptoms
(fever, clear or purulent runny nose, cough, stuffy nose, irritability,
tiredness, loss of appetite, and diarrhea). Children were excluded if
they were diagnosed with acute otitis media as a complication.
Childrenwhowere previously healthy (absence of upper airway
signs and symptoms) and presented the following symptoms in the
last 48 h: fever, cough and/or clear runny nose, with or without the
presence of irritability, tiredness, lack of appetite, and stuffy nose,
were considered to have a non-complicated febrile URI. Other
information obtained included whether or not a physician had
attended to the child, if he/she had prescribed an antibiotic, and if
there were any complications (middle ear infection or acute
sinusitis) during the follow-up.
For analysis purposes, the children were classiﬁed into two
groups: (1) children with non-complicated febrile URI who were
prescribed antibiotics and (2) children with non-complicated
febrile URI who were not prescribed antibiotics.
The study had institutional review board approval (R-2006-
1302-5), and written informed consent was obtained from the
parents for participation in the study.with uncomplicated febrile upper respiratory tract infections (URIs) selected from a
lajara, Jalisco, Mexico (AOM, acute otitis media).
Table 1
Demographic characteristics, mean duration of signs and symptoms, and frequency
of isolation of bacteria in children with febrile URIs, with and without antibiotic use
With antibiotics Without antibiotics p-Value
(n=85) (n=60)
Age, mean SD (years) 2.11.4 2.61.5 0.016a
Gender M=54% M=53% 0.96b
Mean length of signs and symptoms in days
URI 11.1 11.1 0.90a
Fever 1.6 1.5 0.35a
Runny nose 10.1 10 0.77a
Cough 6.6 6.7 0.88a
Stuffy nose 2.4 1.8 0.21a
Irritability 1.7 1.9 0.61a
Tiredness 1.4 1.1 0.16a
Loss of appetite 0.85 1.27 0.12a
Diarrhea 0.21 0.27 0.67a
Bacterial isolates (%)
Haemophilus inﬂuenzae 40 45 0.54b
Streptococcus pneumoniae 19 20 0.86b
Streptococcus pyogenes 11 3.3 0.12b
URI, upper respiratory tract infection; M, male; F, female; SD, standard deviation.
a Student’s t-test.
b Comparison of two proportions.
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Figure 2. Natural history of signs and symptoms associated with febrile upper
respiratory infections (URI) in 145 children with and without the administration of
antibiotics. The x-axis shows each of the 15 days of prospective follow-up and the y-
axis the percentage of children with some of the signs and symptoms associated
with febrile URI. (The continuous lines represent those children who received an
antibiotic and the dashed lines represent those children who did not receive an
antibiotic.).
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A nasopharyngeal culture was taken with a calcium alginate
swab and transported to the laboratory in Stuart transport
medium. The samples were inoculated in 5% sheep blood agar
and a chocolate agar with bacitracin (2.5 U/ml) less than an hour
after being taken. The plates were incubated at 37 8C in a 5% CO2
atmosphere for 18–24 h. The identiﬁcation of S. pneumoniae, H.
inﬂuenzae, and S. pyogenes was done using conventional methods.
Testing of susceptibility to antibiotics was done using the Kirby–
Bauer method, according to the Clinical and Laboratory Standards
Institute (CLSI) 2007 criteria.15
To calculate the sample size we assumed a 20% difference in the
proportion of children with fever by the third day of evolution (in
favor of those who received an antibiotic), and a conﬁdence
interval of 95%, giving a total of 60 children per group (those with
and those without the prescription of antibiotics).
2.3. Statistical analysis
Descriptive statistical analyses (frequencies, averages, and
standard deviations) and comparative statistical analyses (com-
parison of proportions between two independent groups, Student’s
t-test, and one-way analysis of variance (ANOVA)) were carried out
using SPSS v.11.0 (SPSS Inc., Chicago, IL, USA). A p-value of 0.05
was considered signiﬁcant.
3. Results
Of the 880 children attending the seven daycare centers, 153
children were enrolled (only one episode per child) after
being reported by the nurse as having a febrile URI. Eight
of the 153 children were excluded – seven who presented
an acute middle ear infection and one who was lost to follow-up.
Figure 1 shows details of how many children were referred to
be seen by a physician, the number of those who presented at
their clinic appointment, and the proportion of those who
received an antibiotic, both those prescribed by a physician and
those not.
Themean age of the childrenwho received an antibiotic (n = 85;
59%) was lower than that of those who did not (n = 60; 41%)
(mean  standard deviation 2.1  1.4 years vs. 2.6  1.5 years,
respectively; p = 0.016). With respect to gender, in the ﬁrst group
54% were boys, while in the second group 53% were boys (p = 0.96).
There were no gender differences with respect to the administration
of analgesics/antipyretics (p = 0.42) (Table 1).
Given the differences found in the ages of the children who
received antibiotics and those who did not, the duration of signs
and symptoms were compared after arbitrarily stratifying them
into two groups: group A, children from 6months to 2 years of age
(n = 63) and group B, children from 2 years 1 month to 5 years 11
months of age (n = 82); no signiﬁcant differences were identiﬁed.
With regard to the duration of the signs and symptoms of
febrile URI in the groups who received or did not receive
antibiotics, the second group allowed us to create a graph
representing the ‘natural history of the disease’ and we compared
this to those who received antibiotics (Figure 2). When comparing
the average days of each sign and symptom in the children with
and without antibiotics, it was evident that there were no
signiﬁcant differences with regard to fever (1.6 vs. 1.5; p = 0.35),
runny nose (10.1 vs. 10; p = 0.77), stuffy nose (2.4 vs. 1.8; p = 0.21),
cough (6.6 vs. 6.7; p = 0.88), irritability (1.7 vs. 1.9; p = 0.61), loss of
appetite (0.85 vs. 1.27; p = 0.12), tiredness (1.4 vs. 1.1; p = 0.16), or
diarrhea (0.21 vs. 0.27; p = 0.67) (Table 1).
The type of antibiotic administered was recorded for 85/145
children; b-lactams were administered in 55%, cephalosporins in18%, macrolides in 14%, and trimethoprim–sulfamethoxazole
(TMP–SMX) in 13% .
With respect to the microbiology in those children given
antibiotics compared to those not given antibiotics, no signiﬁcant
differences were found in relation to the proportions of isolated H.
inﬂuenzae (40 vs. 45%; p = 0.54), S. pneumoniae (19 vs. 20%;
p = 0.86), and S. pyogenes (11 vs. 3.3%; p = 0.12) (Table 1). There
were no differences in the proportions of susceptible, intermediate,
or resistant strains (data not shown).
An additional analysis was performed to evaluate the outcomes
(main duration of URI and each of the signs and symptoms
evaluated) in children with or without a bacterial isolate (S.
pneumoniae, H. inﬂuenzae and S. pyogenes), as well as those who
received different types of antibiotic (b-lactams, cephalosporins,
macrolides, and TMP–SMX). As shown in Table 2, there were no
differences between children with and those without H. inﬂuenzae
or S. pyogenes isolates. However, children from whom S.
pneumoniae were isolated had both a signiﬁcantly longer episode
of URI, as well as a longer duration of diarrhea. Children receiving
TMP–SMX treatment also has a signiﬁcantly longer duration of
fever and diarrhea (Table 2).
Table 2
Analysis of outcome according to bacterial isolates and antibiotic treatments
Signs and symptoms p-Valuea for children with
and without an
H. inﬂuenzae isolate




with and without an
S. pyogenes isolate
p-Valueb for antibiotic groups (b-lactams,
cephalosporins, macrolides, TMP–SMX)
URI 0.55 0.01 0.07 0.46
Fever 0.21 0.60 0.90 0.03
Runny nose 0.75 0.34 0.29 0.18
Cough 0.72 0.26 0.14 0.60
Stuffy nose 0.99 0.34 0.24 0.13
Irritability 0.86 0.62 0.65 0.36
Tiredness 0.83 0.64 0.67 0.94
Loss of appetite 0.32 0.56 0.42 0.80
Diarrhea 0.55 0.04 0.29 0.04
URI, upper respiratory tract infection; TMP–SMX, trimethoprim–sulfamethoxazole.
a Student’s t-test.
b One-way analysis of variance (ANOVA).
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Acute upper respiratory tract infections are the primary cause
of morbidity in the general population of Mexico and in children
under 10 years of age, with a prevalence of 49%.16 In children who
attend daycare centers, URI are the primary cause of infectious
disease, followed by diarrheal diseases.17,18
In this study the prevalence of URI could not be determined
because the nurse did not report all cases with a febrile URI and
because some had already been medicated with analgesics/
antipyretics or even with antibiotics at home by the mother.
The average duration of the respiratory signs and symptoms in
children with a non-complicated febrile URI was 11 days, and was
comparable in children who were prescribed antibiotics and in
those who were not. Wald et al.19 described a group of children
aged 1 year who presented URI with an average duration of 9 days;
however, no information about the use and duration of antibiotics
was available. The study of Jain et al.20 in children with URI,
reported that the symptoms lasted 7–10 days. The patients in our
study who managed without antibiotics had a similar natural
history of disease proﬁle to those described by Pappas et al.21 The
comparison of those who used antibiotics and those who did not,
showed their lack of effect on the evolution of the disease (Figure 2)
and suggests a probable viral etiology.
The average of age of children who received antibiotics was
lower than that of those who did not; the younger age group are
more likely to be treated with antibiotics due to a higher
prevalence of URI and a greater risk of bacterial complications.11
Regarding complications of the URI, the reported prevalence of
acute middle ear infections in our study population (4%) wasmuch
lower than that reported in the literature (8–30%);22 this could be
associated with an under-diagnosis by general practitioners who
usually lack an otoscope.
A total of 59% of the children who presented a URI with fever
received an antibiotic, and in the majority of the cases (95%) this
was prescribed during a doctor’s appointment. The prescription of
antibiotics in children with signs and symptoms highly suggestive
of a viral infection has been related to parental pressure on
the family doctor to prescribe them; self-administration, based on
the belief that the antibiotics will reduce the fever period or the
complications, occurs to a lesser extent.7,10,11,23 The limited
usefulness of antibiotics has been described by Petersen et al.24
They demonstrated that in order to avoid one case of pneumonia in
children with a URI, 4407 needed to be treated with antibiotics. In
the samemanner, some clinical guidelines clearly indicate that the
presence of cough, runny nose, conjunctivitis or diarrhea in a child
with URI is a contraindication for the use of antibiotics.25 Overuse
of antibiotics is also associated with an increased pressure for the
development and selection of resistant bacteria.12The fact that no signiﬁcant differences in the prevalence of
isolation of S. pyogenes, H. inﬂuenzae and S. pneumoniae was found
in the children with or without the administration of antibiotics
suggests a carrier state and could explain the lack of clinical beneﬁt
with antibiotics. However, a longer duration of the URI and
diarrhea were found in those children with an S. pneumoniae
isolate, which could be related to true infections with this bacterial
pathogen. No signiﬁcant differencewas found in the length of fever
and all other signs and symptoms evaluated in those with or
without the isolation of any of the three bacteria studied.
Children treated with TMP–SMX had a signiﬁcantly longer
duration of fever and diarrhea. This could also be related to true
URI infections associated with TMP–SMX-resistant pathogens (in
this study 64% of S. pneumoniae and 46% of H. inﬂuenzae strains
were resistant to TMP–SMX).
In conclusion, this study showed that with the exception of
children with S. pneumoniae isolated, in whom the durations of the
URI episode and diarrhea were longer, the clinical outcomes
associated with febrile URI in children attending daycare centers
were comparable in those for whom antibiotics were administered
and in those for whom they were not. The lack of response to
antibiotics and the presence of a cough and runny nose in the
majority of the children should alert the physician to the
possibility of a viral etiology and therefore to avoid the use of
antibiotics.
These results, along with the results of similar studies, should
be used for the elaboration of diagnostic/treatment guidelines for
daycare centers, to limit the use of antibiotics in childrenwith non-
complicated febrile URI.
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